Australia’s largest locally-owned pharmaceutical company specialising in dermatology, Ego Pharmaceuticals, is set to increase its dominance in the country with news it is building a $135 million global headquarters.
The new headquarters, located in Dandenong South, will create 200 new jobs in Victoria by 2017, helping grow the pharmaceutical manufacturing industry in the state and enable Ego Pharmaceuticals to continue its long-term plan of development and growth.
“This development will enable us to grow exponentially and continue to drive our manufacturing and export business. It secures the future of Ego in Victoria to continue to grow and innovate as industry leaders to meet the needs of our consumers,” says Ego managing director Alan Oppenheim.
“We are proud to be driving this growth from Victoria to the world. Australian manufacturing and exporting has significant benefits to the wider economy and we’re committed to continuing to innovate, invest in Australians and lead the industry with our world class practices from state of the art facilities.”
To help celebrate the commencement of building, this week saw the company take part in a soil-turning ceremony attended by Victorian Minister for Industry Lily D'Ambrosio.
